Annabelle Fowler is a panelist during the session titled “Improving Sustainable Biomedical Innovation.”
For more information on this event, click here.
Upper Payment Limits (UPLs) explained
Regulatory shifts create new challenges for pharmaceutical stakeholders. Four states now have PDABs empowered to set UPLs for public payers, and three states...